Susquehanna International Group
TXG icon

Susquehanna International Group’s 10x Genomics TXG Stock Holding History

Susquehanna International Group’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$985K Sell
46,400
-31,200
-40% -$624K ﹤0.01% 7924
2025
Q4 		$1.27M Sell
77,600
-3,600
-4% -$54.4K ﹤0.01% 6633
2025
Q3 		$949K Buy
81,200
+59,800
+279% +$780K ﹤0.01% 7481
2025
Q2 		$248K Buy
+21,400
New +$195K ﹤0.01% 10761
2025
Q1 		– Sell
-22,700
Closed -$326K – 13490
2024
Q4 		$326K Sell
22,700
-13,700
-38% -$216K ﹤0.01% 9643
2024
Q3 		$822K Buy
36,400
+800
+2% +$16.5K ﹤0.01% 7285
2024
Q2 		$692K Buy
35,600
+16,400
+85% +$429K ﹤0.01% 7447
2024
Q1 		$721K Sell
19,200
-11,000
-36% -$483K ﹤0.01% 7637
2023
Q4 		$1.69M Buy
30,200
+6,700
+29% +$292K ﹤0.01% 5724
2023
Q3 		$969K Sell
23,500
-5,000
-18% -$260K ﹤0.01% 6694
2023
Q2 		$1.59M Sell
28,500
-30,500
-52% -$1.65M ﹤0.01% 5626
2023
Q1 		$3.29M Buy
59,000
+6,300
+12% +$294K ﹤0.01% 4143
2022
Q4 		$1.92M Sell
52,700
-35,700
-40% -$1.17M ﹤0.01% 4773
2022
Q3 		$2.52M Buy
88,400
+8,300
+10% +$316K ﹤0.01% 4448
2022
Q2 		$3.63M Buy
80,100
+37,700
+89% +$1.96M ﹤0.01% 3744
2022
Q1 		$3.23M Buy
42,400
+16,000
+61% +$1.4M ﹤0.01% 4487
2021
Q4 		$3.93M Sell
26,400
-199,200
-88% -$30.5M ﹤0.01% 4154
2021
Q3 		$32.8M Buy
225,600
+165,700
+277% +$28.4M ﹤0.01% 1508
2021
Q2 		$11.7M Buy
59,900
+16,600
+38% +$3M ﹤0.01% 2687
2021
Q1 		$7.84M Buy
43,300
+29,500
+214% +$5.09M ﹤0.01% 3166
2020
Q4 		$1.95M Sell
13,800
-11,900
-46% -$1.73M ﹤0.01% 5155
2020
Q3 		$3.2M Sell
25,700
-28,700
-53% -$3.01M ﹤0.01% 3740
2020
Q2 		$4.86M Buy
54,400
+1,500
+3% +$117K ﹤0.01% 3052
2020
Q1 		$3.3M Buy
52,900
+33,300
+170% +$2.6M ﹤0.01% 3138
2019
Q4 		$1.5M Buy
+19,600
New +$1.18M ﹤0.01% 4808

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group's TXG Position: Q1 2026 in Review

Susquehanna International Group increased its 10x Genomics (TXG) stake by 182% in Q1 2026, buying an estimated $1.95M and bringing the position to 150,980 shares worth $3.21M. The position accounts for ﹤0.01% of the portfolio, ranked #5146.

Susquehanna International Group first reported a position in TXG in Q3 2019 and has held it in 23 quarters since. The position peaked at $8.45M in Q1 2025. 329 funds tracked by Wall St. Rank hold TXG as of Q1 2026.

  • Susquehanna International Group held 150,980 shares of 10x Genomics worth $3.21M as of Q1 2026.
  • Susquehanna International Group bought 97,452 10x Genomics shares in Q1 2026, an estimated $1.95M.
  • 10x Genomics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5146 holding.
  • Susquehanna International Group first reported a position in 10x Genomics in Q3 2019 and has held it in 23 quarters since.
  • Susquehanna International Group's 10x Genomics position peaked at $8.45M in Q1 2025.
  • 329 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.